高级检索

    剖宫产术中不同给药时段应用昂丹司琼联合地塞米松的效果比较

    Comparison of the effects of different administration periods of ondansetron combined with dexamethasone during cesarean section

    • 摘要: 目的 探讨不同给药时段应用昂丹司琼联合地塞米松对剖宫产产妇术中及术后恶心呕吐及新生儿结局的影响。方法 选取2024年4月—2025年2月在椎管内麻醉下择期行剖宫产术的产妇148例,年龄18~45岁,ASA分级Ⅱ—Ⅲ级,体重指数(BMI)18~35 kg/m2。采用随机数字表法将产妇分为2组(n=74):椎管内麻醉前给药组(A组)和脐带夹闭后给药组(B组)。A组于椎管内麻醉开始前30 min静脉注射昂丹司琼4 mg和地塞米松4 mg;B组于脐带夹闭后给予相同剂量药物。记录麻醉开始至胎儿娩出(T1)、胎儿娩出至子宫缝合结束(T2)、子宫缝合结束至皮肤缝合结束(T3)、术毕至术后2 h(T4)、术后2~6 h(T5)及术后6~24 h(T6)各时段恶心呕吐的发生率及严重程度。同时采集脐动脉血进行血气分析,并记录新生儿1 min和5 min Apgar评分;记录产妇各时间点心率(HR)、平均动脉压(MAP)、血氧饱和度(SpO2)及不良反应发生情况。结果 与B组相比,A组产妇在T1、T2时段的恶心呕吐发生率显著降低(24.32% vs 10.81%,P=0.031;39.19% vs 17.57%,P=0.004),恶心呕吐评分明显降低(P=0.031;P=0.007)。2组在T3~T6时段恶心呕吐发生率及评分比较,差异均无统计学意义(P>0.05)。2组新生儿体重、脐动脉血气指标、Apgar评分以及产妇生命体征及不良反应发生率比较,差异均无统计学意义(P>0.05)。结论 椎管内麻醉前预防性应用昂丹司琼联合地塞米松可显著降低剖宫产术中早期恶心呕吐的发生,且不影响新生儿结局,具有良好的安全性。

       

      Abstract: Objective To investigate the effects of different administration periods of ondansetron combined with dexamethasone on intraoperative and postoperative nausea and vomiting in cesarean section, as well as neonatal outcomes.Methods A total of 148 parturients, aged 18-45 years, with American Society of Anesthesiologists (ASA) grades Ⅱ—Ⅲ and body mass index (BMI) of 18-35 kg/m2 who underwent elective cesarean section under spinal anesthesia from April 2024 to February 2025 were enrolled. According to the random number table method, they were divided into two groups (n=74): a pre-anesthesia administration group (group A) and a post-umbilical cord clamping administration group (group B). Group A received intravenous ondansetron (4 mg) and dexamethasone (4 mg) 30 min before spinal anesthesia, while group B received the same regimen immediately after umbilical cord clamping. The incidence and severity of nausea and vomiting were recorded during the following time intervals: from initiation of anesthesia to fetal delivery (T1), from fetal delivery to completion of uterine suturing (T2), from completion of uterine suturing to skin closure (T3), from the end of surgery to 2 h postoperatively (T4), from 2 to 6 h postoperatively (T5), and from 6 to 24 h postoperatively (T6). Umbilical arterial blood gas analysis was performed after delivery, and neonatal Apgar scores at 1 min and 5 min were recorded. Maternal heart rate (HR), mean arterial pressure (MAP), oxygen saturation (SpO2), and adverse events were also documented.Results Compared with group B, group A showed a significantly reduced incidence of nausea and vomiting during T1 and T2 (24.32% vs 10.81%, P=0.031; 39.19% vs 17.57%, P=0.004), along with significantly decreased nausea and vomiting scores (P=0.031 and P=0.007, respectively). No significant differences were observed between the two groups during T3-T6 (P>0.05). There were no statistically significant differences between the two groups in neonatal body weight and umbilical arterial blood gas parameters, Apgar scores, maternal vital signs, or incidence of adverse events (P>0.05).Conclusions Prophylactic administration of ondansetron combined with dexamethasone before spinal anesthesia significantly reduces the incidence of early intraoperative nausea and vomiting during cesarean section without adversely affecting neonatal outcomes, demonstrating good safety.

       

    /

    返回文章
    返回